FIGURE 2.

Schematic representation of the use of decellularized biomaterials for cartilage tissue engineering. The cells or tissue-derived biomaterials (A) are subjected to decellarization through physical, enzymatic, or chemical methods (B). The resultant dECM biomaterials can be used to produce scaffold, hydrogel, particle forms, or used as bioinks for 3D printing (C).